Extending the spectrum of precompetitive collaboration in oncology research : workshop summary /

"Despite spending more time and money in developing novel therapeutics, the success rate for new pharmacologic treatments has been poor. Although the research and development expenditures have grown 13 percent each year since 1970 (a 50-fold increase), the number of new drugs approved annually...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Collectivités auteurs: National Cancer Policy Forum (U.S.), Institute of Medicine (U.S.). Board on Health Care Services
Autres auteurs: Patlak, Margie, Nass, Sharyl J., Balogh, Erin
Format: Électronique eBook
Langue:Inglés
Publié: Washington, D.C. : National Academies Press, ©2010.
Sujets:
Oncology > Research > United States > Congresses.
Cancer > Research > United States > Congresses.
Academic-industrial collaboration > United States > Congresses.
Industries.
Schools.
Biomedical Research > economics
Neoplasms
Cooperative Behavior
Industry
Public-Private Sector Partnerships
Schools
Cancérologie > Recherche > États-Unis > Congrès.
Cancer > Recherche > États-Unis > Congrès.
Collaboration université-industrie > États-Unis > Congrès.
Industrie.
Écoles.
MEDICAL > Oncology.
HEALTH & FITNESS > Diseases > Cancer.
Industries
Academic-industrial collaboration
Cancer > Research
Oncology > Research
United States
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Accès en ligne:Texto completo

Internet

Texto completo

Items no disponibles

Informations d'exemplaires de

Documents similaires